Cargando…

Development of SARS‐CoV‐2 animal vaccines using a stable and efficient NDV expression system

With the continuation of the coronavirus disease 2019 pandemic and the emergence of new severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) variants, the control of the spread of the virus remains urgent. Various animals, including cats, ferrets, hamsters, nonhuman primates, minks, tree shr...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Lei, Zhong, Jiaying, Li, Guichang, Lin, Zhengfang, Zhao, Peijing, Yang, Chuhua, Wang, Hairong, Zhang, Yuhao, Yang, Xiaoyun, Wang, Zhongfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874532/ https://www.ncbi.nlm.nih.gov/pubmed/36258299 http://dx.doi.org/10.1002/jmv.28237

Ejemplares similares

SARS-CoV-2-specific CD4(+) T cells are associated with long-term persistence of neutralizing antibodies
por: Wang, Zhongfang, et al.
Publicado: (2022)

SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants
por: Wang, Junxiang, et al.
Publicado: (2022)

Induction of Immune Response in Animal Model Using Recombinant Anti-NDV Vaccine
por: Shahriari, Amir Ghaffar, et al.
Publicado: (2019)

Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection
por: Wang, Bin, et al.
Publicado: (2014)

Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV
por: Roohani, Kiarash, et al.
Publicado: (2015)

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens
por: Ferreira, Helena L., et al.
Publicado: (2021)

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
por: Sun, Weina, et al.
Publicado: (2020)

Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge
por: Yang, Xin, et al.
Publicado: (2016)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein
por: Chumbe, Ana, et al.
Publicado: (2017)

SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
por: Yang, Gang, et al.
Publicado: (2023)

Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges
por: Tan, Lei, et al.
Publicado: (2020)

RECEPTOR DESTRUCTION BY VIRUSES OF THE MUMPS-NDV-INFLUENZA GROUP
por: Hirst, George K.
Publicado: (1950)

Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection
por: Wang, Zhongfang, et al.
Publicado: (2021)

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants
por: Zhong, Jiaying, et al.
Publicado: (2022)

Recombinant Newcastle Disease Virus (NDV) Expressing Sigma C Protein of Avian Reovirus (ARV) Protects against Both ARV and NDV in Chickens
por: Saikia, Deep Prakash, et al.
Publicado: (2019)

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
por: Sun, Weina, et al.
Publicado: (2020)

Single-Dose Vaccination of Recombinant Chimeric Newcastle Disease Virus (NDV) LaSota Vaccine Strain Expressing Infectious Bursal Disease Virus (IBDV) VP2 Gene Provides Full Protection against Genotype VII NDV and IBDV Challenge
por: Qiao, Qilong, et al.
Publicado: (2021)

Use of cracked maize as a carrier for NDV(4 )vaccine in experimental vaccination of chickens
por: Olabode, Atanda O, et al.
Publicado: (2010)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Identification of a new amino acid mutation in the HN protein of NDV involved in pathogenicity
por: Chen, Xi, et al.
Publicado: (2021)

The effects of different velogenic NDV infections on the chicken bursa of Fabricius
por: Kristeen-Teo, Y. W., et al.
Publicado: (2017)

Functional characterization of goose IRF1 in IFN induction and anti-NDV infection
por: Lin, Zhenyu, et al.
Publicado: (2022)

Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants
por: Zhao, Zhuxiang, et al.
Publicado: (2022)

Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge
por: Ding, Ke, et al.
Publicado: (2018)

Recombinant Newcastle disease virus (NDV) expressing Duck Tembusu virus (DTMUV) pre-membrane and envelope proteins protects ducks against DTMUV and NDV challenge
por: Sun, Minhua, et al.
Publicado: (2018)

NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization
por: Sui, Hong, et al.
Publicado: (2017)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
por: Tcheou, Johnstone, et al.
Publicado: (2021)

MECHANISM OF PRODUCTION OF PULMONARY LESIONS IN MICE BY NEWCASTLE DISEASE VIRUS (NDV)
por: Ginsberg, Harold S.
Publicado: (1951)

Flavone ingredients can synergistically inhibit NDV infecting cell and improve ND vaccine's protective rate
por: Yuqing, Zhang, et al.
Publicado: (2012)

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
por: Singh, Shakti, et al.
Publicado: (2019)

NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice
por: Alqarihi, Abdullah, et al.
Publicado: (2019)

Complex Involvement of the Extracellular Matrix, Immune Effect, and Lipid Metabolism in the Development of Idiopathic Pulmonary Fibrosis
por: Qian, Weiping, et al.
Publicado: (2022)

shRNA-triggered RNAi inhibits expression of NDV NP gene in chicken embryo fibroblast
por: Yue, Hua, et al.
Publicado: (2008)

Anti-NDV activity of baicalin from a traditional Chinese medicine in vitro
por: JIA, Yan, et al.
Publicado: (2016)

Targeting STAT3 enhances NDV‐induced immunogenic cell death in prostate cancer cells
por: Wang, Xueke, et al.
Publicado: (2020)

THE RELATIONSHIP OF THE RECEPTORS OF A NEW STRAIN OF VIRUS TO THOSE OF THE MUMPS-NDV-INFLUENZA GROUP
por: Hirst, George K.
Publicado: (1950)

NDV-induced apoptosis in absence of Bax; evidence of involvement of apoptotic proteins upstream of mitochondria
por: Molouki, Aidin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cfdtkgi31m7qeggviognrf7pnh